Introduction: cardiotoxicity remains the most serious complication of anticancer chemotherapy, especially if it manifests by heart failure. Early detection of myocardial involvement, before alteration of LVEF, would involve the necessary measures to be taken to prevent progression to heart failure.
Aim: Early detection of the cadiotoxicity of anti-cancer chemotherapy, through clinical, echocardiographic and biological parameters.
Background: The FAST-MI Tunisia registry was set up by the Tunisian Society of Cardiology and Cardiovascular Surgery to assess the demographic and clinical characteristics, management and hospital outcome of patients with ST-elevation myocardial infarction (STEMI).
Methods: Data for 459 consecutive patients (mean age 60.8 years; 88.
Objective: To determine the incidence of peripheral venous catheters-related adverse events (PVCAEs).
Methods: We conducted a prospective observational study in the cardiology department over a period of 3 months. All inserted PVCs were monitored (every 12 hours) from insertion to up to 48 hours after removal.
Unlabelled: FAST-MI Tunisian registry was initiated by the Tunisian Society of Cardiology and Cardio-vascular Surgery to assess characteristics, management, and hospital outcomes in patients with ST-elevation myocardial infarction (STEMI).
Methods: We prospectively collected data from 203 consecutive patients (mean age 60.3 years, 79.